| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013338 |
| Receipt No. | R000015568 |
| Official scientific title of the study | Accuracy of subcutaneous continuous glucose monitor during perioperative period |
| Date of disclosure of the study information | 2014/03/06 |
| Last modified on | 2016/04/08 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Accuracy of subcutaneous continuous glucose monitor during perioperative period
|
|
| Title of the study (Brief title) | Accuracy of subcutaneous continuous glucose monitor | |
| Region |
|
|
| Condition | ||
| Condition | Hepatocellular carcinoma, Pancreas tumor, Esophageal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Aim of this study is examined the accuracy of a subcutaneous continuous glucose monitor during perioperative period. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Difference between glucose measured by subcutaneous continuous glucose monitor and glucose measured by artificial pancreas. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subcutaneous continuous glucose monitor | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Schedule operated patient of liver, pancreas and esophagus
|
|||
| Key exclusion criteria | Patients who was not used an artificial pancreas for perioperative glucose control | |||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiro Hanazaki |
| Organization | Kochi Medical School |
| Division name | Surgery |
| Address | Kohasu, Oko-cho, Nankoku, Kochi, Japan |
| TEL | 088-880-2370 |
| hanazaki@kochi-u.ac.jp | |
| Public contact | |
| Name of contact person | Tomoaki Yatabe |
| Organization | Kochi Medical School |
| Division name | Anesthesiology |
| Address | Kohasu, Oko-cho, Nankoku, Kochi, Japan |
| TEL | 088-880-2471 |
| Homepage URL | |
| yatabe@kochi-u.ac.jp | |
| Sponsor | |
| Institute | Department of Surgery, Kochi Medical School |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Surgery, Kochi Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://www.ncbi.nlm.nih.gov/pubmed/26721825 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000015568 |